- Home
- ELVN vs ROOT Comparison
ELVN vs ROOT Comparison
Compare ELVN & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$27.02
Company Overview
Basic Information| Metric | ELVN | ROOT |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 804.6M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELVN | ROOT |
|---|---|---|
| Price | $27.02 | $45.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $41.00 | ★ $97.80 |
| AVG Volume (30 Days) | ★ 648.7K | 363.5K |
| Earning Date | 06-05-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.17 | ★ 28.96 |
| EPS | N/A | ★ 2.36 |
| Revenue | N/A | ★ $1,517,100,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | $40.06 | $12.63 |
| P/E Ratio | ★ N/A | $19.75 |
| Revenue Growth | N/A | ★ 28.95 |
| 52 Week Low | $13.30 | $42.65 |
| 52 Week High | $30.98 | $181.14 |
Technical Indicators
Market Signals| Indicator | ELVN | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 36.34 |
| Support Level | $25.10 | N/A |
| Resistance Level | $29.63 | $63.33 |
| Average True Range (ATR) | 1.58 | 2.48 |
| MACD | -0.45 | 0.18 |
| Stochastic Oscillator | 1.40 | 21.35 |
Price Performance
Historical Comparison ELVN
ROOT
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.